SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-13-005440
Filing Date
2013-09-30
Accepted
2013-09-30 08:31:34
Documents
11
Period of Report
2013-09-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k092413_soligenix.htm 8-K 33616
2 AWARD f8k092413ex10i_soligenix.htm EX-10.1 597843
3 AWARDED CONTRACT f8k092413ex99i_soligenix.htm EX-99.1 19568
4 img001.jpg GRAPHIC 2560
5 img002.jpg GRAPHIC 189430
6 img003.jpg GRAPHIC 52353
7 img004.jpg GRAPHIC 53813
8 img005.jpg GRAPHIC 17934
9 img006.jpg GRAPHIC 22223
10 img007.jpg GRAPHIC 36034
11 img008.jpg GRAPHIC 55302
  Complete submission text file 0001213900-13-005440.txt   1245304
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16929 | Film No.: 131121370
SIC: 2834 Pharmaceutical Preparations